Change in Representative Director and President and Departure of the Head of the China Healthcare Business
First written in FY2020. . Latest entry: FY2021.
43 other companies' latest entry also says "Other".
- FY2021Appointment of a Successor PresidentAnnual report
「Representative Director and Chairman: Che Lucho Representative Director and President: Mori Kinya」
Following Yang Xiaojun's departure as representative director and president, Che Lucho became representative director and chairman and Mori Kinya became representative director and president. - FY2020First statedAnnual report
「The Company's healthcare business in China had been led principally by Yang Xiaojun, the Company's former representative director and president. However, as disclosed in the notice dated 12 February 2021 regarding the change in representative directors, Yang Xiaojun resigned as representative director, president and director, ceased to have any relationship with the Company or any of its subsidiaries, and left the business. The Company therefore determined that it would be difficult to continue the Chinese healthcare business in its current form.」
Yang Xiaojun resigned as representative director, president and director on 12 February 2021 and left the Chinese healthcare business. Che Lvzhao became representative director and president.